Concepedia

Author

Guillaume Bouguen

Centre Hospitalier Universitaire de RennesORCID

Also Known As

Bouguen Guillaume, Bouguen, G, Bouguen, G., Bouguen, Guillaume, G Bouguen, G. BOUGUEN, G. Bouguen, Gilles Macaigne, Guillaume Bouguen, Harry Sokol

354

Publications

8.9K

Citations

46

H-Index

90

Concepts

All Affiliations

Centre Hospitalier Universitaire de RennesInsermUniversité de RennesHôpital PontchaillouAssistance Publique – Hôpitaux de Paris
GB

About

Guillaume Bouguen is an author at Centre Hospitalier Universitaire de Rennes specializing in medicine, gastroenterology, and surgery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

26

37

2.1K

2

Public Health

6

6

229

3

Health Sciences

1

1

19

4

Allergy

1

1

20

5

Cell Biology

1

1

17

Guillaume Bouguen

×

111

Publications

5.2K

Citations

41

H-Index

YearCitations

Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study

Yoram Bouhnik, Franck Carbonnel, David Laharie,

Gut

2017

315

Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools

Anthony Buisson, Florent Gonzalez, Florian Poullenot,

Inflammatory Bowel Diseases

2017

223

Long-term Outcome of Perianal Fistulizing Crohn's Disease Treated With Infliximab

Guillaume Bouguen, Laurent Siproudhis, Emmanuel Gizard,

Clinical Gastroenterology and Hepatology

2013

204

Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease

Aurélien Amiot, Jean–Charles Grimaud, Laurent Peyrin‐Biroulet,

Clinical Gastroenterology and Hepatology

2016

189

One‐year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study

Aurélien Amiot, Mélanie Serrero, Laurent Peyrin‐Biroulet,

Alimentary Pharmacology & Therapeutics

2017

175

Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn’s Disease Refractory to Anti–Tumor Necrosis Factor Agents

Pauline Wils, Yoram Bouhnik, Pierre Michetti,

Clinical Gastroenterology and Hepatology

2015

169

Endoscopic Assessment and Treating to Target Increase the Likelihood of Mucosal Healing in Patients With Crohn’s Disease

Guillaume Bouguen, Barrett G. Levesque, Suresh Pola,

Clinical Gastroenterology and Hepatology

2013

134

Fistula Plug in Fistulising Ano-Perineal Crohn’s Disease: a Randomised Controlled Trial

A. Senéjoux, Laurent Siproudhis, Laurent Abramowitz,

Journal of Crohn s and Colitis

2015

125

Development of the IBD Disk

Subrata Ghosh, Édouard Louis, Laurent Beaugerie,

Inflammatory Bowel Diseases

2017

116

Impact of vedolizumab therapy on extra‐intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the <scp>OBSERV</scp>‐<scp>IBD</scp> cohort

S. Tadbiri, Laurent Peyrin‐Biroulet, Mélanie Serrero,

Alimentary Pharmacology & Therapeutics

2017

109

Page 1